Minireview: Cyclin D1: Normal and abnormal functions

Endocrinology

Volumn 145, Issue 12, 2004, Pages 5439-5447

  Fu, Maofu ^a   Wang, Chenguang ^a   Li, Zhiping ^a   Sakamaki, Toshiyuki ^a   Pestell, Richard G ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE; HISTONE; HOLOENZYME; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR;

ACETYLATION; CARCINOGENESIS; CELL CYCLE; CHROMATIN; GENE AMPLIFICATION; GENE OVEREXPRESSION; METASTASIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SHORT SURVEY;

ANIMALS; CYCLIN D1; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; TRANSCRIPTION, GENETIC;

EID: 9444236895     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2004-0959     Document Type: Short Survey

References (125)

1. Liu MC, Marshall JL, Pestell RG 2004 Novel strategies in cancer therapeutics: targeting enzymes involved in cell cycle regulation and cellular proliferation. Curr Cancer Drug Targets 4:403-424
2. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM, Arnold A 1991 A novel cyclin encoded by a bell-linked candidate oncogene. Nature 350:512-515
3. Sherr CJ, Rettenmier CW, Sacca R, Roussel MF, Look AT, Stanley ER 1985 The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 41:665-676
4. Imanishi Y, Hosokawa Y, Yoshimoto K, Schipani E, Mallya S, Papanikolaou A, Kifor O, Tokura T, Sablosky M, Ledgard F, Gronowicz G, Wang TC, Schmidt EV, Hall C, Brown EM, Bronson R, Arnold A 2001 Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice. J Clin Invest 107:1093-1102
5. Neumeister P, Pixley FJ, Xiong Y, Xie H, Wu K, Ashton A, Cammer M, Chan A, Symons M, Stanley ER, Pestell RG 2003 Cyclin d1 governs adhesion and motility of macrophages. Mol Biol Cell 14:2005-2015
6. Wang C, Li Z, Fu M, Bouras T, Pestell RG 2004 Signal transduction mediated by cyclin D1: from mitogens to cell proliferation: a molecular target with therapeutic potential. Cancer Treat Res 119:217-237
7. Sherr CJ 2004 Principles of tumor suppression. Cell 116:235-246
8. Hanahan D, Weinberg RA 2000 The hallmarks of cancer. Cell 100:57-70
9. Albanese C, D'Amico M, Reutens AT, Fu M, Watanabe G, Lee RJ, Kitsis RN, Henglein B, Avantaggiati M, Somasundaram K, Thimmapaya B, Pestell RG 1999 Activation of the cyclin D1 gene by the E1A-associated protein p300 through AP-1 inhibits cellular apoptosis. J Biol Chem 274:34186-34195
10. Holnthoner W, Pillinger M, Groger M, Wolff K, Ashton AW, Albanese C, Neumeister P, Pestell RG, Petzelbauer P 2002 Fibroblast growth factor-2 induces Lef/Tcf-dependent transcription in human endothelial cells. J Biol Chem 277:45847-45853
11. Nelsen CJ, Rickheim DG, Tucker MM, McKenzie TJ, Hansen LK, Pestell RG, Albrecht JH 2003 Amino acids regulate hepatocyte proliferation through modulation of cyclin D1 expression. J Biol Chem 278:25853-25858
12. Hu YL, Albanese C, Pestell RG, Jaffe RB 2003 Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells. J Natl Cancer Inst 95:733-740
13. Fu M, Rao M, Wang C, Sakamaki T, Wang J, Di Vizio D, Zhang X, Albanese C, Balk S, Chang C, Fan S, Rosen E, Palvimo JJ, Janne OA, Muratoglu S, Avantaggiati ML, Pestell RG 2003 Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth. Mol Cell Biol 23:8563-8575
14. Suzui M, Masuda M, Lim JT, Albanese C, Pestell RG, Weinstein IB 2002 Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21 (CIP1) and inhibition of expression of cyclin D1. Cancer Res 62:3997-4006
15. Wang C, Pattabiraman N, Zhou JN, Fu M, Sakamaki T, Albanese C, Li Z, Wu K, Hulit J, Neumeister P, Novikoff PM, Brownlee M, Scherer PE, Jones JG, Whitney KD, Donehower LA, Harris EL, Rohan T, Johns DC, Pestell RG 2003 Cyclin D1 repression of peroxisome proliferator-activated receptor γ expression and transactivation. Mol Cell Biol 23:6159-6173
16. Iyengar P, Combs TP, Shah SJ, Gouon-Evans V, Pollard JW, Albanese C, Flanagan L, Tenniswood MP, Guha C, Lisanti MP, Pestell RG, Scherer PE 2003 Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization. Oncogene 22:6408-6423
17. Song DH, Rana B, Wolfe JR, Crimmins G, Choi C, Albanese C, Wang TC, Pestell RG, Wolfe MM 2003 Gastrin-induced gastric adenocarcinoma growth is mediated through cyclin D1. Am J Physiol Gastrointest Liver Physiol 285:G217-G222
18. Pradeep A, Sharma C, Sathyanarayana P, Albanese C, Fleming JV, Wang TC, Wolfe MM, Baker KM, Pestell RG, Rana B 2004 Gastrin-mediated activation of cyclin D1 transcription involves β-catenin and CREB pathways in gastric cancer cells. Oncogene 23:3689-3699
19. Beier F, Ali Z, Mok D, Taylor AC, Leask T, Albanese C, Pestell RG, LuValle P 2001 TGFβ and PTHrP control chondrocyte proliferation by activating cyclin D1 expression. Mol Biol Cell 12:3852-3863
20. Hanai J, Dhanabal M, Karumanchi SA, Albanese C, Waterman M, Chan B, Ramchandran R, Pestell R, Sukhatme VP 2002 Endostatin causes G1 arrest of endothelial cells through inhibition of cyclin D1. J Biol Chem 277:16464-16469
21. ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J Biol Chem 270:23589-23597
22. Lee RJ, Albanese C, Stenger RJ, Watanabe G, Inghirami G, Haines 3rd GK, Webster M, Muller WJ, Brugge JS, Davis RJ, Pestell RG 1999 pp60(v-src) Induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways. A role for cAMP response element-binding protein and activating transcription factor-2 in pp60(v-src) signaling in breast cancer cells. J Biol Chem 274:7341-7350
23. Lee RJ, Albanese C, Fu M, D'Amico M, Lin B, Watanabe G, Haines 3rd GK, Siegel PM, Hung MC, Yarden Y, Horowitz JM, Muller WJ, Pestell RG 2000 Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway. Mol Cell Biol 20:672-683
24. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, Ben-Ze'ev A 1999 The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 96:5522-5527
25. Lin SY, Xia W, Wang JC, Kwong KY, Spohn B, Wen Y, Pestell RG, Hung MC 2000 β-Catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci USA 97:4262-4266
26. Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, Darnell Jr JE 1999 Stat3 as an oncogene. Cell 98:295-303
27. Kim MO, Si Q, Zhou JN, Pestell RG, Brosnan CF, Locker J, Lee SC 2002 Interferon-β activates multiple signaling cascades in primary human microglia. J Neurochem 81:1361-1371
28. Matsumura I, Kitamura T, Wakao H, Tanaka H, Hashimoto K, Albanese C, Downward J, Pestell RG, Kanakura Y 1999 Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells. EMBO J 18:1367-1377
29. Watanabe G, Howe A, Lee RJ, Albanese C, Shu IW, Karnezis AN, Zon L, Kyriakis J, Rundell K, Pestell RG 1996 Induction of cyclin D1 by simian virus 40 small tumor antigen. Proc Natl Acad Sci USA 93:12861-12866
30. Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G 1993 Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 7:812-821
31. Sherr CJ 2000 The Pezcoller Lecture: cancer cell cycles revisited. Cancer Res 60:3689-3695
32. Motokura T, Arnold A 1993 PRAD1/cyclin D1 proto-oncogene: genomic organization, 5′ DNA sequence, and sequence of a tumor-specific rearrangement breakpoint. Genes Chromosomes Cancer 7:89-95
33. Zhang YJ, Jiang W, Chen CJ, Lee CS, Kahn SM, Santella RM, Weinstein IB 1993 Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem Biophys Res Commun 196:1010-1016
34. Bartkova J, Lukas J, Muller H, Lutzhoft D, Strauss M, Bartek J 1994 Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 57:353-361
35. Afar DE, McLaughlin J, Sherr CJ, Witte ON, Roussel MF 1995 Signaling by ABL oncogenes through cyclin D1. Proc Natl Acad Sci USA 92:9540-9544
36. Callanan M, Leroux D, Magaud JP, Rimokh R 1996 Implication of cyclin D1 in malignant lymphoma. Crit Rev Oncog 7:191-203
37. Gansauge S, Gansauge F, Ramadani M, Stobbe H, Rau B, Harada N, Beger HG 1997 Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis. Cancer Res 57:1634-1637
38. Barnes DM, Gillett CE 1998 Cyclin D1 in breast cancer. Breast Cancer Res Treat 52:1-15
39. Amanatullah DF, Zafonte BT, Albanese C, Fu M, Messiers C, Hassell J, Pestell RG 2001 Ras regulation of cyclin D1 promoter. Methods Enzymol 333:116-127
40. Diehl JA 2002 Cycling to cancer with cyclin D1. Cancer Biol Ther 1:226-231
41. Stacey DW 2003 Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells. Curr Opin Cell Biol 15:158-163
42. Chung DC 2004 Cyclin D1 in human neuroendocrine: tumorigenesis. Ann NY Acad Sci 1014:209-217
43. Oyama T, Kashiwabara K, Yoshimoto K, Arnold A, Koerner F 1998 Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast. Cancer Res 58:2876-2880
44. Shoker BS, Jarvis C, Davies MP, Iqbal M, Sibson DR, Sloane JP 2001 Immunodetectable cyclin D(1) is associated with oestrogen receptor but not Ki67 in normal, cancerous and precancerous breast lesions. Br J Cancer 84:1064-1069
45. Luo RX, Postigo AA, Dean DC 1998 Rb interacts with histone deacetylase to repress transcription. Cell 92:463-473
46. Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T 1998 Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391:597-601
47. Zhang HS, Gavin M, Dahiya A, Postigo AA, Ma D, Luo RX, Harbour JW, Dean DC 2000 Exit from G1 and S phase of the cell cycle is regulated by represser complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell 101:79-89
48. Harbour JW, Luo RX, Dei Santi A, Postigo AA, Dean DC 1999 Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 98:859-869
49. Dey A, Li W 2000 Cell cycle-independent induction of D1 and D2 cyclin expression, but not cyclin-Cdk complex formation or Rb phosphorylation, by IFNγ in macrophages. Biochim Biophys Acta 1497:135-147
50. Pestell RG, Albanese C, Reutens AT, Segall JE, Lee RJ, Arnold A 1999 The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr Rev 20:501-534
51. Zhang JM, Wei Q, Zhao X, Paterson BM 1999 Coupling of the cell cycle and myogenesis through the cyclin D1-dependent interaction of MyoD with cdk4. EMBO J 18:926-933
52. Horstmann S, Ferrari S, Klempnauer KH 2000 Regulation of B-Myb activity by cyclin D1. Oncogene 19:298-306
53. Inoue K, Sherr CJ 1998 Gene expression and cell cycle arrest mediated by transcription factor DMP1 is antagonized by D-type cyclins through a cyclin-dependent-kinase-independent mechanism. Mol Cell Biol 18:1590-1600
54. Knudsen KE, Cavenee WK, Arden KC 1999 D-type cyclins complex with the androgen receptor and inhibit its transcriptional transactivation ability. Cancer Res 59:2297-2301
55. Reutens AT, Fu M, Wang C, Albanese C, McPhaul MJ, Sun Z, Balk SP, Janne OA, Palvimo JJ, Pestell RG 2001 Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/CBP-associated factor (P/ CAF)-dependent manner. Mol Endocrinol 15:797-811
56. Petre CE, Wetherill YB, Danielsen M, Knudsen KE 2002 Cyclin D1: mechanism and consequence of androgen receptor co-repressor activity. J Biol Chem 277:2207-2215
57. Petre-Draviam CE, Cook SL, Burd CJ, Marshall TW, Wetherill YB, Knudsen KE 2003 Specificity of cyclin D1 for androgen receptor regulation. Cancer Res 63:4903-4913
58. Zwijsen RM, Wientjens E, Klompmaker R, van der Sman J, Bernards R, Michalides RJ 1997 CDK-independent activation of estrogen receptor by cyclin D1. Cell 88:405-415
59. Neuman E, Ladha MH, Lin N, Upton TM, Miller SJ, DiRenzo J, Pestell RG, Hinds PW, Dowdy SF, Brown M, Ewen ME 1997 Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol Cell Biol 17:5338-5347
60. Lamb J, Ladha MH, McMahon C, Sutherland RL, Ewen ME 2000 Regulation of the functional interaction between cyclin D1 and the estrogen receptor. Mol Cell Biol 20:8667-8675
61. Qin C, Burghardt R, Smith R, Wormke M, Stewart J, Safe S 2003 Peroxisome proliferator-activated receptor γ agonists induce proteasome-dependent degradation of cyclin D1 and estrogen receptor α in MCF-7 breast cancer cells. Cancer Res 63:958-964
62. McMahon C, Suthiphongchai T, DiRenzo J, Ewen ME 1999 P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor. Proc Natl Acad Sci USA 96:5382-5387
63. Lamb J, Ewen ME 2003 Cyclin D1 and molecular chaperones: implications for tumorigenesis. Cell Cycle 2:525-527
64. Adnane J, Shao Z, Robbins PD 1999 Cyclin D1 associates with the TBP-associated factor TAF(II)250 to regulate Sp1-mediated transcription. Oncogene 18:239-247
65. Siegert JL, Rushton JJ, Sellers WR, Kaelin Jr WG, Robbins PD 2000 Cyclin D1 suppresses retinoblastoma protein-mediated inhibition of TAFII250 kinase activity. Oncogene 19:5703-5711
66. Zwicker J, Brusselbach S, Jooss KU, Sewing A, Behn M, Lucibello FC, Muller R 1999 Functional domains in cyclin D1: pRb-kinase activity is not essential for transformation. Oncogene 18:19-25
67. Weinstein IB 1996 Relevance of cyclin D1 and other molecular markers to cancer chemoprevention. J Cell Biochem Suppl 25:23-28
68. Mallya SM, Arnold A 2000 Cyclin D1 in parathyroid disease. Front Biosci 5:D367-D371
69. Arnold A, Motokura T, Bloom T, Kronenberg H, Ruderman J, Juppner H, Kim HG 1991 The putative oncogene PRAD1 encodes a novel cyclin. Cold Spring Harb Symp Quant Biol 56:93-97
70. Hemmer S, Wasenius VM, Haglund C, Zhu Y, Knuutila S, Franssila K, Joensuu H 2001 Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations in parathyroid adenomas. Am J Pathol 158:1355-1362
71. Vasef MA, Brynes RK, Sturm M, Bromley C, Robinson RA 1999 Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study. Mod Pathol 12:412-416
72. Tominaga V, Tsuzuki T, Uchida K, Haba T, Otsuka S, Ichimori T, Yamada K, Numano M, Tanaka Y, Takagi H 1999 Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma. Kidney Int 55:1375-1383
73. Hsi ED, Zukerberg LR, Yang WI, Arnold A 1996 Cyclin D1/PRAD1 expression in parathyroid adenomas: an immunohistochemical study. J Clin Endocrinol Metab 81:1736-1739
74. Hosokawa Y, Arnold A 1998 Mechanism of cyclin D1 (CCND1, PRAD1) overexpression in human cancer cells: analysis of allele-specific expression. Genes Chromosomes Cancer 22:66-71
75. Kong S, Amos CI, Luthra R, Lynch PM, Levin B, Frazier ML 2000 Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer. Cancer Res 60:249-252
76. Kong S, Wei Q, Amos CI, Lynch PM, Levin B, Zong J, Frazier ML 2001 Cyclin D1 polymorphism and increased risk of colorectal cancer at young age. J Natl Cancer Inst 93:1106-1108
77. Wang L, Habuchi T, Takahashi T, Mitsumori K, Kamoto T, Kakehi Y, Kakinuma H, Sato K, Nakamura A, Ogawa O, Kato T 2002 Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer. Carcinogenesis 23:257-264
78. Bala S, Peltomaki P 2001 CYCLIN D1 as a genetic modifier in hereditary nonpolyposis colorectal cancer. Cancer Res 61:6042-6045
79. Wang L, Habuchi T, Mitsumori K, Li Z, Kamoto T, Kinoshita H, Tsuchiya N, Sato K, Ohyama C, Nakamura A, Ogawa O, Kato T 2003 Increased risk of prostate cancer associated with AA genotype of cyclin D1 gene A870G polymorphism. Int J Cancer 103:116-120
80. Le Marchand L, Seifried A, Lum-Jones A, Donlon T, Wilkens LR 2003 Association of the cyclin D1 A870G polymorphism with advanced colorectal cancer. JAMA 290:2843-2848
81. Sawa H, Ohshima TA, Ukita H, Murakami H, Chiba Y, Kamada H, Hara M, Saito I 1998 Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner. Oncogene 16:1701-1712
82. Solomon DA, Wang Y, Fox SR, Lambeck TC, Giesting S, Lan Z, Senderowicz AM, Knudsen ES 2003 Cyclin D1 splice variants: differential effects on localization, RB phosphorylation and cellular transformation. J Biol Chem 278:30339-30347
83. Sicinski P, Donaher JL, Parker SB, Li T, Fazeli A, Gardner H, Haslam SZ, Bronson RT, Elledge SJ, Weinberg RA 1995 Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82:621-630
84. Fantl V, Stamp G, Andrews A, Rosewell I, Dickson C 1995 Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev 9:2364-2372
85. Tong W, Pollard JW 2001 Genetic evidence for the interactions of cyclin D1 and p27(Kip1) in mice. Mol Cell Biol 21:1319-1328
86. Geng Y, Yu Q, Sicinska E, Das M, Bronson RT, Sicinski P 2001 Deletion of the p27Kip1 gene restores normal development in cyclin D1-deficient mice. Proc Natl Acad Sci USA 98:194-199
87. Geng Y, Yu Q, Sicinska E, Das M, Schneider JE, Bhattacharya S, Rideout WM, Bronson RT, Gardner H, Sicinski P 2003 Cyclin E ablation in the mouse. Cell 114:431-443
88. Gladden AB, Diehl JA 2003 Cell cycle progression without cyclin E/CDK2: breaking down the walls of dogma. Cancer Cell 4:160-162
89. Ortega S, Prieto I, Odajima J, Martin A, Dubus P, Sotillo R, Barbero JL, Malumbres M, Barbacid M 2003 Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice. Nat Genet 35:25-31
90. Hinds PW, Dowdy SF, Eaton EN, Arnold A, Weinberg RA 1994 Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci USA 91:709-713
91. Robles AI, Rodriguez-Puebla ML, Click AB, Trempus C, Hansen L, Sicinski P, Tennant RW, Weinberg RA, Yuspa SH, Conti CJ 1998 Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo. Genes Dev 12:2469-2474
92. Lovec H, Sewing A, Lucibello FC, Muller R, Moroy T 1994 Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation. Oncogene 9:323-326
93. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV 1994 Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369:669-671
94. Bortner DM, Rosenberg MP 1997 Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E. Mol Cell Biol 17:453-459
95. Bodrug SE, Warner BJ, Bath ML, Lindeman GJ, Harris AW, Adams JM 1994 Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J 13:2124-2130
96. Yu Q, Geng Y, Sicinski P 2001 Specific protection against breast cancers by cyclin D1 ablation. Nature 411:1017-1021
97. Hatsell S, Rowlands T, Hiremath M, Cowin P 2003 β-Catenin and Tcfs in mammary development and cancer. J Mammary Gland Biol Neoplasia 8:145-158
98. Hulit J, Wang C, Albanese C, Di Vizio D, Mahmood R, Augenlicht LH, Russell R, Pestell RG 2004 Cyclin D1 genetic heterozygosity regulates colonic epithelial cell differentiation and tumor number in ApcMin mice. Mol Cell Biol 24:7598-7611
99. Zwijsen RM, Buckle RS, Hijmans EM, Loomans CJ, Bernards R 1998 Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1. Genes Dev 12:3488-3498
100. Hwang TS, Han HS, Hong YC, Lee HJ, Paik NS 2003 Prognostic value of combined analysis of cyclin D1 and estrogen receptor status in breast cancer patients. Pathol Int 53:74-80
101. Han S, Park K, Bae BN, Kim KH, Kim HJ, Kim YD, Kim HY 2003 Cyclin D1 expression and patient outcome after tamoxifen therapy in estrogen receptor positive metastatic breast cancer. Oncol Rep 10:141-144
102. Rosen ED, Spiegelman BM 2000 Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol 16:145-171
103. Koeffler HP 2003 Peroxisome proliferator-activated receptor γ and cancers. Clin Cancer Res 9:1-9
104. Lamb J, Ramaswamy S, Ford HL, Contreras B, Martinez RV, Kittrell FS, Zahnow CA, Patterson N, Golub TR, Ewen ME 2003 A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 114:323-334
105. Neuhold LA, Wold B 1993 HLH forced dimers: tethering MyoD to E47 generates a dominant positive myogenic factor insulated from negative regulation by Id. Cell 74:1033-1042
106. Braun T, Bober E, Arnold HH 1992 Inhibition of muscle differentiation by the adenovirus E1a protein: repression of the transcriptional activating function of the HLH protein Myf-5. Genes Dev 6:888-902
107. Rudnicki MA, Braun T, Hinuma S, Jaenisch R 1992 Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development. Cell 71:383-390
108. Lassar AB, Davis RL, Wright WE, Kadesch T, Murre C, Voronova A, Baltimore D, Weintraub H 1991 Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell 66:305-315
109. Rao SS, Chu C, Kohtz DS 1994 Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators. Mol Cell Biol 14:5259-5267
110. Skapek SX, Rhee J, Kim PS, Novitch BG, Lassar AB 1996 Cyclin-mediated inhibition of muscle gene expression via a mechanism that is independent of pRB hyperphosphorylation. Mol Cell Biol 16:7043-7053
111. Naya FJ, Stellrecht CM, Tsai MJ 1995 Tissue-specific regulation of the insulin gene by a novel basic helix-loop-helix transcription factor. Genes Dev 9:1009-1019
112. Ratineau C, Petry MW, Mutoh H, Leiter AB 2002 Cyclin D1 represses the basic helix-loop-helix transcription factor, BETA2/NeuroD. J Biol Chem 277:8847-8853
113. Takeda K, Kishimoto T, Akira S 1997 Signal transducer and activator of transcription protein (STAT): its relation to Th1/Th2-mediated diseases. Nutrition 13:987-988
114. Bienvenu F, Gascan H, Coqueret O 2001 Cyclin D1 represses STAT3 activation through a Cdk4-independent mechanism. J Biol Chem 276:16840-16847
115. Brockman JL, Schroeder MD, Schuler LA 2002 PRL activates the cydin D1 promoter via the Jak2/Stat pathway. Mol Endocrinol 16:774-784
116. Quintanilla-Martinez L, Kremer M, Specht K, Calzada-Wack J, Nathrath M, Schaich R, Hofler H, Fend F 2003 Analysis of signal transducer and activator of transcription 3 (Stat 3) pathway in multiple myeloma: Stat3 activation and cyclin D1 dysregulation are mutually exclusive events. Am J Pathol 162:1449-1461
117. Simon AR, Takahashi S, Severgnini M, Fanburg BL, Cochran BH 2002 Role of the JAK-STAT pathway in PDGF-stimulated proliferation of human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 282:L1296-L1304
118. Turkson J, Jove R 2000 STAT proteins: novel molecular targets for cancer drug discovery. Oncogene 19:6613-6626
119. Sala A, Calabretta B 1992 Regulation of BALB/c 3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression. Proc Natl Acad Sci USA 89:10415-10419
120. Lin HM, Zhao L, Cheng SY 2002 Cyclin D1 is a ligand-independent co-repressor for thyroid hormone receptors. J Biol Chem 277:28733-28741
121. Chan HM, Ktstic-Demonacos M, Smith L, Demonacos C, La Thangue NB 2001 Acetylation control of the retinoblastoma tumour-suppressor protein. Nat Cell Biol 3:667-674
122. Zhao J, Pestell R, Guan JL 2001 Transcriptional activation of cyclin D1 promoter by FAK contributes to cell cycle progression. Mol Biol Cell 12:4066-4077
123. D'Amico M, Hulit J, Amanatullah DF, Zafonte BT, Albanese C, Bouzahzah B, Fu M, Augenlicht LH, Donehower LA, Takemaru K, Moon RT, Davis R, Lisanti MP, Shtutman M, Zhurinsky J, Ben-Ze'ev A, Troussard AA, Dedhar S, Pestell RG 2000 The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3β and cAMP-responsive element-binding protein-dependent pathways. J Biol Chem 275:32649-32657
124. Bohmer RM, Scharf E, Assoian RK 1996 Cytoskeletal integrity is required throughout the mitogen stimulation phase of the cell cycle and mediates the anchorage-dependent expression of cyclin D1. Mol Biol Cell 7:101-111
125. Felsenfeld G, Groudine M 2003 Controlling the double helix. Nature 421:448-453